A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

Clinical trial NCT03690154 · TERMINATED

Trial details

NCT number: NCT03690154
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Solid Tumors Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia, in Relapse

Start date: 2018-07-23
Primary completion: 2022-02-11
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.